BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8208745)

  • 1. Comparative in vitro diffusion studies for atenolol transdermal delivery system.
    Demou JS; Sidhom MB; Plakogiannis FM
    Pharm Acta Helv; 1994 May; 68(4):215-9. PubMed ID: 8208745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and in vitro permeation studies of proniosomal based transdermal delivery system of Atenolol.
    Ramkanth S; Chetty CM; Sudhakar Y
    Pak J Pharm Sci; 2014 Jan; 27(1):115-20. PubMed ID: 24374439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluation of the release of albuterol sulfate from polymer gels: effect of fatty acids on drug transport across biological membranes.
    Chisty MN; Bellantone RA; Taft DR; Plakogiannis FM
    Drug Dev Ind Pharm; 2002 Nov; 28(10):1221-9. PubMed ID: 12476868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro transdermal delivery of atenolol using mouse and guinea pig.
    Jain GK; Kaul JL; Agrawal SS
    Indian J Exp Biol; 1993 Aug; 31(8):691-3. PubMed ID: 8270284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation, in-vitro and in-vivo characterization of transdermal patch containing glibenclamide and atenolol: a combinational approach.
    Anitha P; Ramkanth S; Saleem MT; Umasankari K; Reddy BP; Chetty M
    Pak J Pharm Sci; 2011 Apr; 24(2):155-63. PubMed ID: 21454164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation and controlled release characteristics of modified xanthan films for transdermal delivery of atenolol.
    Mundargi RC; Patil SA; Agnihotri SA; Aminabhavi TM
    Drug Dev Ind Pharm; 2007 Jan; 33(1):79-90. PubMed ID: 17192254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of matrix-membrane transdermal drug delivery system for atenolol.
    Gupta SP; Jain SK
    Drug Deliv; 2004; 11(5):281-6. PubMed ID: 15742552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal delivery system of triamcinolone acetonide from a gel using phonophoresis.
    Yang JH; Kim DK; Yun MY; Kim TY; Shin SC
    Arch Pharm Res; 2006 May; 29(5):412-7. PubMed ID: 16756087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insight into transdermal drug delivery with supersaturated formulation based on co-amorphous system.
    Hirakawa Y; Ueda H; Miyano T; Kamiya N; Goto M
    Int J Pharm; 2019 Oct; 569():118582. PubMed ID: 31381987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative permeation/release study of different testosterone gel formulations.
    Pabla D; Zia H
    Drug Deliv; 2007 Aug; 14(6):389-96. PubMed ID: 17701528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo transdermal studies of atenolol using iontophoresis.
    Inal O; Kiliçarslan M; Ari N; Baykara T
    Acta Pol Pharm; 2008; 65(1):29-36. PubMed ID: 18536170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
    Aboofazeli R; Zia H; Needham TE
    Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal-controlled administration of oxycodone.
    Tien JH
    J Pharm Sci; 1991 Aug; 80(8):741-3. PubMed ID: 1791532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
    Yang Z; Teng Y; Wang H; Hou H
    Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced transdermal delivery of atenolol from the ethylene-vinyl acetate matrix.
    Cho CW; Shin SC
    Int J Pharm; 2004 Dec; 287(1-2):67-71. PubMed ID: 15541913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A long acting ophthalmic gel formulations of atenolol.
    Hassan MA
    Drug Dev Ind Pharm; 2007 Nov; 33(11):1192-8. PubMed ID: 18058315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viscoelastic properties of Carbopol 940 gels and their relationships to piroxicam diffusion coefficients in gel bases.
    A-sasutjarit R; Sirivat A; Vayumhasuwan P
    Pharm Res; 2005 Dec; 22(12):2134-40. PubMed ID: 16215775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of tretinoin gels for enhanced transdermal delivery.
    Shin SC; Kim HJ; Oh IJ; Cho CW; Yang KH
    Eur J Pharm Biopharm; 2005 May; 60(1):67-71. PubMed ID: 15848058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of polyunsaturated fatty acids and some conventional penetration enhancers on transdermal delivery of atenolol.
    Puglia C; Bonina F
    Drug Deliv; 2008 Feb; 15(2):107-12. PubMed ID: 18293196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and in-vivo evaluation of ondansetron gels for transdermal delivery.
    Patel DR; Joshi A; Patel HH; Stagni G
    Drug Dev Ind Pharm; 2015 Jun; 41(6):1030-6. PubMed ID: 24919508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.